您当前的位置:
首页 >
文章列表页 >
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer
- “研究人员开发了PRIME,这是一种可解释的AI模型,整合了ctDNA MRD、突变和临床特征,用于预测早期NSCLC的治疗失败风险。神经网络在训练和验证集中实现了0.85和0.82的AUC,优于单一生物标志物,并能够做出个性化的辅助治疗决策。”
- Military Medical Research 2026年13卷第5期 页码:747-765
DOI: 10.1186/s40779-025-00679-z
录用:2025-11-25
移动端阅览
AI导读
HTML全文
图( 6 ) 表( 0 )
参考文献
出版信息
数据统计
56
浏览量
59
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Enhancing the clinical relevance of haemorrhage prediction models in trauma
Artificial intelligence and machine learning for hemorrhagic trauma care
Sepsis in burns: lessons learned, challenges remain
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
相关作者
Sankalp Tandle
Jared M. Wohlgemut
Max E. R. Marsden
Erhan Pisirir
Evangelia Kyrimi
Rebecca S. Stoner
William Marsh
Zane B. Perkins
相关机构
Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London
The Royal London Hospital, Barts Health NHS Trust
Academic Department of Military Surgery and Trauma, Research and Clinical Innovation, The Royal Centre for Defence Medicine
Department of Electronic Engineering and Computer Science, Queen Mary University of London
Sunnybrook Health Sciences Centre

